United States· US:66758-085_0afb6589-51ba-432c-aed1-20a12d5d3455
Azopt
A brinzolamide product containing brinzolamide, registered in United States by Sandoz Inc. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Brinzolamide is registered in 18 of 19 countries.
Countries holding a registration under ATC S01EC04 (brinzolamide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Brinzolamide · ATC S01EC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BRINZOLAMIDE
- Manufacturer
- Sandoz Inc
- Country
- United States (US)
- ATC code
- S01EC04
- ATC class
- Brinzolamide
- Defined daily dose
- 0.2 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1166758-085-70
- ndc1166758-085-85
- ndc1166758085701 BOTTLE in 1 CARTON (66758-085-70) / 10 mL in 1 BOTTLE
- ndc1166758085851 BOTTLE in 1 CARTON (66758-085-85) / 15 mL in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
43 interactions on record for brinzolamide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Brinzolamide · interactions on record
43 records
- 4 severe
- 39 info
Most severe, free to view
- Acetylsalicylic acidB01AC06severe
- Salicylic acidD01AE12severe
- Acetylsalicylic acidN02BA01severe
- Salicylic acidS01BC08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Brinzolamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAZOPTNovartis Europharm Limited, Dublin
- NetherlandsAZOPT 10 mg/ml oogdruppels, suspensieNovartis Europharm Limited
- FranceAZOPT 10 mg/ml, collyre en suspensionNOVARTIS EUROPHARM (IRLANDE)
- FinlandAZOPTNovartis Europharm Limited
- NorwayAzopt2care4 ApS
- IrelandAzopt 10 mg/ml eye drops, suspensionNovartis Europharm Limited
- BelgiumAzopt 10 mg/mlPI Pharma
- PolandAzoptNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Aicisi, Brinzo-Vision
- Bulgaria · Бритил
- Czechia · Brinzolamid Olikla, Brinzolamide Stada
- Germany · Aicisi, Brinzo-Vision
- Denmark · Brinzolamid Stada, Brinzolamide Hexal
- Estonia · Brinzolamide Elvim, Brinzolamide Hexal
- Spain · Aicisi, Brinzolamida Stada
- Finland · Brinzolamide Accord, Brinzolamide Hexal
- France · Aicisi, Brinzolamide Arrow
- United Kingdom (Northern Ireland) · Brinzolamide Accord-Uk, Brinzolamide Blumont Pharma
- Greece · Aicisi, Optonium
- Ireland · Brinzolamide Accord Healthcare Ireland, Brinzolamide Rowex
- Iceland · Azopt
- Italy · Aicisi, Brinzaflux
- Liechtenstein · Azopt
- Lithuania · Brinzolamide Elvim
- Latvia · Brinzolamide Elvim, Brinzolamide Hexal
- Netherlands · Brinzo-Vision, Brinzolamide Pharmathen
- Norway · Azopt, Brinzolamide Hexal
- Poland · Optilamid
- Portugal · Aicisi, Brinzolamida Accord
- Sweden · Brinzolamid Stada, Brinzolamide Accord
- Slovakia · Brinzolamid Olikla, Brizadopt
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95a2b6e9-b0a0-40f2-9075-66670438ff0e GET /v1/drugs/95a2b6e9-b0a0-40f2-9075-66670438ff0e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "10",
"substance": "BRINZOLAMIDE",
"productndc": "66758-085",
"dosage_form": "SUSPENSION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA020816",
"marketing_category": "NDA"
}See everything about brinzolamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.